FDA Inspection 1161714 — LUNGPACER MEDICAL USA INC
The FDA completed an inspection of LUNGPACER MEDICAL USA INC on Dec 16, 2021 in Exton, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 16, 2021
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Exton, PA (United States)
Additional Details
Sponsor, Contract Research Organization